235 results
Page 3 of 12
8-K
xaboq
4 Oct 21
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
p61b gp7q
5 Aug 21
Unaudited Pro Forma Consolidated Financial Statements of Adamis Pharmaceuticals Corporation
5:07pm
PREC14A
fz0ajg
23 Jun 21
Preliminary proxy with contested solicitation
4:17pm
DEFC14A
fmp jmt0h1moi
14 Jun 21
Proxy in contested solicitation
6:01am
PREC14A
mfbam mzi
1 Jun 21
Preliminary proxy with contested solicitation
10:06am
424B5
n1n7nmu66v f7xqtdmc
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
lbqzwg12gbee
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
424B5
ejkdzj3 z936
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
ys22jdsxsoy 33
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
8sdpv4j gklumz
21 Sep 20
Prospectus supplement for primary offering
6:03am
8-K
EX-1.1
6ctemfmumebuus8
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
424B5
hloidghbuy4zzsyb7g
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-99.1
ern0gw7866t7s6hnh
18 Aug 20
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business Update
12:00am